Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-29T11:48:26.230Z Has data issue: false hasContentIssue false
  • English
  • Français

Post-mortem studies in affective disorder1

Published online by Cambridge University Press:  09 July 2009

I. N. Ferrier  and
E. K. Perry
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Psychological Medicine , Volume 22 , Issue 4 , November 1992 , pp. 835 - 838
Copyright
Copyright © Cambridge University Press 1992

References

REFERENCES

Altshuler, L. L., Casanova, M. F., Goldberg, T. E. & Kleinman, J. E. (1990). The hippocampus and parhippocampus in schizophrenic suicide and control brains. Archives of General Psychiatry 47, 1029–1034.CrossRefGoogle ScholarPubMed
Altshuler, L. L., Conrad, A., Hauser, P., Li, X., Guze, B. L., Deniskoff, K., Tourtelotte, W. & Post, R. (1991). Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging. Archives of General Psychiatry 48, 482–483.Google ScholarPubMed
Arango, V., Ernsberger, P., Marzuk, P. M., Chen, J., Tierney, H., Stanley, M., Reis, D. J. & Mann, J. J. (1990). Autoradiographic demonstration of increased serotonin 5-HT2 and β-adrenergic receptor binding sites in the brains of suicide victims. Archives of General Psychiatry 47, 1038–1047.CrossRefGoogle ScholarPubMed
Biggins, J. A., Perry, E. K., McDermott, J. R., Smith, A. I., Perry, R. H. & Edwardson, J. A. (1983). Postmortem levels of thyrotropic releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression. Journal of Neurological Science 58, 117–122.CrossRefGoogle Scholar
Charlton, B. G., Cheetham, S. C., Harton, R. W., Katona, C. L. E., Crompton, M. R. & Ferrier, I. N. (1988). Corticotrophin-releasing factor immunoreactivity in post-mortem brain from depressed suicides. Journal of Psychopharmacology 2, 13–18.CrossRefGoogle Scholar
Cheetham, S. C., Crompton, M. R., Katona, C. L. E. & Horton, R. W. (1988). Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Research 443, 272–280.CrossRefGoogle ScholarPubMed
Cheetham, S. C., Crompton, M. R., Katona, C. L. E. & Horton, R. W. (1990). Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology 102, 544–548.CrossRefGoogle ScholarPubMed
Deakin, J. F. W. (1989). 5HT receptor subtypes in depression. In Behavioural Pharmacology of 5HT (ed. Archer, T., Bevan, P. and Cools, A.), pp. 179–204. Laurence Erlbaum: New York.Google Scholar
Ferrier, I. N., McKeith, I. G., Cross, A. J., Perry, E. K., Candy, J. M. & Perry, R. H. (1986). Postmortem neurochemical studies in depression. Annals of the New York Academy of Sciences 487, 128–142.CrossRefGoogle ScholarPubMed
Leake, A., Perry, E. K., Perry, R. H., Fairbairn, A. F. & Ferrier, I. N. (1990). Cortical concentrations of corticotrophin releasing factor and its receptor in Alzheimer-type dementia and major depression. Biological Psychiatry 28, 603–608.CrossRefGoogle ScholarPubMed
Levy, A. B., Drake, H. E. & Shy, K. E. (1988). EEG evidence of epileptiform paroxysms in rapid cycling bipolar patients. Journal of Clinical Psychiatry 49, 232–234.Google ScholarPubMed
Mayeux, R., Stern, Y., Sano, M., Williams, B. W. & Coté, L. J. (1988). The relationship of serotonin to depression in Parkinson's disease. Movement Disorders 3, 237–244.CrossRefGoogle ScholarPubMed
Nemeroff, C. B., Widerlov, E., Bissette, G., Walleus, H., Karlsson, I., Ekland, K., Kitt, C. D., Loosen, P. T. & Vale, W. (1984). Elevated concentrations of CSF corticotrophin-releasing factor-like immunoreactivity in depressed patients. Science 226, 1342–1344.CrossRefGoogle Scholar
Nemeroff, C. B., Owens, M. J., Bissette, G., Andom, A. C. & Stanley, M. (1988). Reduced corticotrophin-releasing factor binding sites in the frontal cortex of suicide victims. Archives of General Psychiatry 45, 577–579.CrossRefGoogle ScholarPubMed
Perry, E. K. (1986). The cholinergic hypothesis – ten years on. British Medical Bulletin 42, 63–69.CrossRefGoogle Scholar
Perry, E. K. & Perry, R. H. (1983). Human brain neurochemistry: some postmortem problems. Life Sciences 33, 1733–1743.CrossRefGoogle ScholarPubMed
Perry, E. K., Johnson, M., Kerwin, J. M., Piggott, M. A., Court, J. A., Ince, P. G., Shaw, P. & Perry, R. H. (1992). Converging archicortical cholinergic activities in aging and Alzheimer's disease. Neurobiology of Aging (in the press).CrossRefGoogle Scholar
Perry, R. H. (1986). Recent advances in neuropathology. British Medical Bulletin 42, 34–41.CrossRefGoogle ScholarPubMed
Perry, R. H., Irving, D., Blessed, G., Fairbairn, A. F. & Perry, E. K. (1990). Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. Journal of the Neurological Sciences 95, 119–139.CrossRefGoogle ScholarPubMed
Piggott, M., Sahgal, A. & Perry, E. K. (1992) Examination of parameters influencing [3H]MK801 binding in postmortem human cortex. Journal of Neurochemistry 58, 1001–1009.CrossRefGoogle ScholarPubMed
Sapolsky, R. M. (1987). Glucorticoids and hippocampal damage. Trends in Neuroscience 10, 346–349.CrossRefGoogle Scholar
Welner, S. A., De Montigny, C., Desroches, J., Desjardins, P. & Suranyi-Cadotte, B. E. (1989). Autoradiographic quantitation of serotonin,1A receptors in rat brain following antidepressant drug treatment. Synapse 4, 347–352.CrossRefGoogle Scholar
Yates, M. & Ferrier, I. N. (1990). 5HT1A receptors in major depression. Journal of Psychopharmacology 4, 69–74.CrossRefGoogle ScholarPubMed
Yates, M., Leake, A., Candy, J. M., Fairbairn, A. F., McKeith, I. G. & Ferrier, I. N. (1990). 5HT2 receptor changes in major depression. Biological Psychiatry 27, 489–496.CrossRefGoogle ScholarPubMed
Zubenko, G. S., Moosy, J. & Koop, U. (1990). Neurochemical correlates of major depression in primary dementia. Archives of neurology 47, 209–214.CrossRefGoogle ScholarPubMed
Zwieg, R. M., Ross, C. A., Hedreen, J. C., Steele, C., Cordillo, J. E., Whitehouse, P. J., Folstein, M. A. & Price, D. L. (1988). The neuropathology of the aminergic nuclei in Alzheimer's disease. Annals of Neurology 24, 233–242.CrossRefGoogle Scholar